LEVISTA
Generic: LevetiracetamAntiepileptic
- Product information at a glance
- Available strengths
- 250 mg500 mg
- Dosage form
- Film-coated tablet, Solution
- Pack sizes
- Each box contains 3x10 tablets in Alu-PVC blister.Each box contains 2x10 tablets in Alu-PVC blister.Each bottle contains 100 ml of oral solution.
Strengths, dosage forms and pack sizes are taken from the product composition and packing information below.
Composition
- Levista™ 250 Tablet: Each film coated tablet contains Levetiracetam USP 250 mg.
- Levista™ 500 Tablet: Each film coated tablet contains Levetiracetam USP 500 mg.
- Levista™ 100 ml Oral Solution: Each 5 ml solution contains Levetiracetam USP 500 mg.
Indications
Levista™ (tablet and oral solution) is indicated as adjunctive therapy in the treatment of:
- Partial onset seizures in patients one month of age and older with epilepsy
- Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy
- Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy
Presentation & packing
- Levista™ 250 Tablet: Each box contains 3x10 tablets in Alu-PVC blister.
- Levista™ 500 Tablet: Each box contains 2x10 tablets in Alu-PVC blister.
- Levista™ 100 ml Oral Solution: Each bottle contains 100 ml of oral solution.
Leaflet & prescribing information
Distributor enquiry
Speak to the NAAFCO Pharma export and distribution team about supply, pack sizes and availability of LEVISTA.

